Investor Presentation • Nov 18, 2025
Investor Presentation
Open in ViewerOpens in native device viewer
{0}------------------------------------------------

{1}------------------------------------------------
This presentation includes "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, and such statements are based on current expectations and assumptions that are subject to risks and uncertainties. All statements other than statements of historical facts included in this presentation, including, without limitation, statements regarding the anticipated benefits (including synergies and cash flow) of the acquisition and integration of KCA Deutag, the anticipated impact of the acquisition of KCA Deutag on the Company's business and future financial and operating results, the anticipated timing of expected synergies, cost savings and returns from the acquisition of KCA Deutag, the anticipated impact of suspended rigs related to the Acquisition, outlook for fiscal 2026, the Company's business strategy, future financial position, operations outlook, future cash flow, future use of generated cash flow, dividend amounts and timing, amounts of any future dividends, investments, active rig count projections, projected costs and plans, objectives of management for future operations, contract terms, financing and funding, debt reduction plans, capex spending and budgets, outlook for domestic and international markets, future commodity prices, and future customer activity and relationships are forward-looking statements. For information regarding risks and uncertainties associated with the Company's business, please refer to the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections and other disclosures in the Company's SEC filings, including but not limited to its annual report on Form 10-K and quarterly reports on Form 10-Q. As a result of these factors, Helmerich & Payne, Inc.'s actual results may differ materially from those indicated or implied by such forward-looking statements. Investors are cautioned not to put undue reliance on such statements. We undertake no duty to publicly update or revise any forward-looking statements, whether as a result of new information, changes in internal estimates, expectations or otherwise, except as required under applicable securities laws.
Helmerich & Payne uses its Investor Relations website as a channel of distribution for material company information. Such information is routinely posted and accessible on its Investor Relations website at www.hpinc.com. Information on our website is not part of this presentation.
The data included in this presentation regarding the oil field services industry, including trends in the market and the Company's position and the position of its competitors within this industry, are based on the Company's estimates, which have been derived from management's knowledge and experience in the industry, and information obtained from customers, trade and business organizations, internal research, publiclyavailable information, industry publications and surveys and other contacts in the industry. The Company has also cited information compiled by industry publications, governmental agencies and publicly-available sources. Although the Company believes these third-party sources to be reliable, it has not independently verified the data obtained from these sources and it cannot assure you of the accuracy or completeness of the data. Estimates of market size and relative positions in a market are difficult to develop and inherently uncertain and the Company cannot assure you that it is accurate. Accordingly, you should not place undue weight on the industry and market share data presented in this presentation.
Statements made in this presentation include non-GAAP financial measures. The required reconciliations to U.S. GAAP financial measures are included at the end of this presentation.

{2}------------------------------------------------


(2) Does not include 27 rigs that have suspended operations in Saudi Arabia.
{3}------------------------------------------------

{4}------------------------------------------------
H&P's market share in the Permian Basin has expanded from 29% to ~35% over the past five years(1)

{5}------------------------------------------------
H&P is the most efficient driller in the U.S. and plans to demonstrate we can do the same in key international markets



{6}------------------------------------------------
H&P is in active dialogue with operators throughout the MENA region



{7}------------------------------------------------
| North America Solutions |
International Solutions |
Offshore Solutions |
Other | |
|---|---|---|---|---|
| Direct Margin1 (\$MMs) |
\$242.0 | \$29.5 | \$34.8 | \$(9.5) |
| Exit Rigs/Mgmt. Cont. | 144 | 61(2) | 35 | N / A |
| Q4 Fiscal 2025 | \$MMs |
|---|---|
| Adjusted EBITDA(1) | \$225 |
| Diluted EPS | \$(0.58) |
| Adjusted EPS(1) | \$(0.01) |
| Cash Flow From Operating Activities | \$211 |
| Net Capital Expenditures(1) | \$53.3 |
| Free Cash Flow | \$153.7 |

(1) Direct Margin, Adjusted EBITDA, Adjusted EPS, and Net Capex are non-GAAP financial measures; see the Appendix for GAAP reconciliations.
(2) Does not include 27 rigs that have suspended operations in Saudi Arabia, as of November 17th.
{8}------------------------------------------------
Expect continual progress on cost discipline and de-leveraging
| Q1 Fiscal 2026 Guidance Items | North America Solutions |
International Solutions |
Offshore Solutions |
Other |
|---|---|---|---|---|
| Direct Margin1 (\$MMs) |
\$225-\$250 | \$13-\$23 | \$27-\$33 | \$3-\$7 |
| Avg. Rigs/Mgmt. Cont. | 138-144 | 57-63(2) | 30-35 | N / A |
| Full Fiscal Year 2026 Guidance Items | \$MMs | |
|---|---|---|
| Gross Capital Expenditures | \$280-\$320 | Reflects a step-down from FY25 levels |
| Depreciation | \$690 | |
| Research and Development | \$25 | |
| Selling, General & Administrative | \$265-\$285 | (3) |
| Cash Taxes | \$95-\$145 | |
| Interest Expense | \$100 |

(1) Direct Margin is a non-GAAP measure
(2) Does not include 27 rigs that have suspended operations in Saudi Arabia, as of November 17th
(3) Sequential decline relative to proforma annualized 2025
{9}------------------------------------------------
FY26 guidance represents a sizeable sequential decrease versus last few years

{10}------------------------------------------------
A Differentiated Global Drilling Business
H&P can drive profitable growth across diverse global markets
Forward-thinking commercial strategies and advanced technologies set H&P apart
Financial strength underpins growth, dividend stability, and disciplined deleveraging

{11}------------------------------------------------

{12}------------------------------------------------
| Regions | Rigs Available2 |
Rigs Contracted1 |
% Contracted |
|---|---|---|---|
| North America Solutions | 203 | 143 | 70% |
| International Solutions | 137 | 59 | 43% |
| Middle East3 | 77 | 374 | 48% |
| South America | 34 | 13 | 38% |
| Rest of World | 26 | 9 | 38% |
| Offshore Solutions | 5 | 3 | 60% |
| Total Fleet | 345 | 205 | 59% |
(1) Contracted rig count as of 11/17/2025
(2) 99% of H&P's rigs in North America Solutions are super-spec
(3) Includes rigs in Saudi Arabia, Oman, Kuwait, and Bahrain
(4) Does not include 27 rigs that have suspended operations in Saudi Arabia, as of November 17th
{13}------------------------------------------------
| Total Liquidity \$1.17 B Cash and Undrawn Credit Facility |
Debt Reduction Goal Over \$400 M In 2025-2026 |
|---|---|
| Credit Rating BBB/Baa2 Investment Grade at S&P & Moody's |
Cost Savings Over \$50 M FY26 SG&A guidance is over \$50M lower than relative proforma annualized FY25 |
| Q4 Adj. EBITDA(1) \$225 M Exceeding consensus |
Dividend Yield ~4% Competitive Within OFS |
| Type | Amount | Maturity | Interest Rate(2) |
|---|---|---|---|
| Term Loan | \$190 M | Jan. 2027 | 5.79% |
| 3-yr Bond | \$350 M | Dec. 2027 | 4.65% |
| 5-yr Bond | \$350 M | Dec. 2029 | 4.85% |
| 10-yr Bond | \$550 M | Sept. 2031 | 2.90% |
| 10-yr Bond | \$550 M | Dec. 2034 | 5.50% |
| Total Debt | \$1,990 M(3) | 4.55% |
| Type | Amount |
|---|---|
| Undrawn Credit Facility | \$950 M |
| Cash & Short-Tern Investments(4) | \$218 M |
| Total Liquidity | \$1,168 M |

{14}------------------------------------------------
| Three Months Ended | Year Ended | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (in thousands) | September 30, 2025 |
June 30, 2025 |
September 30 2024 |
September 30, 2025 |
September 30, 2024 |
|||||||
| NORTH AMERICA SOLUTIONS | ||||||||||||
| Segment operating income | \$ | 118,158 | \$ | 157,649 | \$ | 155,593 | \$ | 579,961 | \$ | 610,623 | ||
| Add back: | ||||||||||||
| Depreciation and amortization | 88,248 | 88,078 | 92,647 | 351,813 | 366,446 | |||||||
| Research and development | 7,580 | 7,617 | 8,975 | 34,140 | 41,293 | |||||||
| Selling, general and administrative expense | 25,781 | 10,972 | 17,301 | 68,047 | 61,113 | |||||||
| Acquisition transaction costs | _ | 7 | _ | 41 | _ | _ | ||||||
| Asset impairment charge | _ | _ | _ | 1,507 | B | _ | ||||||
| Restructuring charges | 2,272 | 1,849 | 4,121 | _ | ||||||||
| Direct margin (Non-GAAP) | \$ | 242,039 | \$ | 266,172 | \$ | 274,516 | \$ | 1,039,630 | \$ | 1,079,475 | ||
| INTERNATIONAL SOLUTIONS | ||||||||||||
| Segment operating income (loss) | \$ | (75,715) | s | (166,513) | s | (3,954) | s | (291,695) | s | 4.652 | ||
| Add back: | * | (, ) | * | (123,212) | • | (0,00.7) | * | (== 1,===) | • | 1,552 | ||
| Depreciation and amortization | 90,102 | 66,734 | 3,314 | 218,817 | 10,863 | |||||||
| Selling, general and administrative expense | 4,964 | 5,014 | 2,093 | 17,232 | 9,427 | |||||||
| Acquisition transaction costs | 1,234 | 141 | _ | 1,585 | _ | |||||||
| Asset impairment charge | 4,368 | 128,352 | _ | 132,720 | _ | |||||||
| Restructuring charges | 4,565 | 380 | _ | 4,945 | _ | |||||||
| Direct margin (Non-GAAP) | \$ | 29,518 | \$ | 34,108 | \$ | 1,453 | \$ | 83,604 | \$ | 24,942 | ||
| OFFSHORE SOLUTIONS | ||||||||||||
| Segment operating income | \$ | 20.293 | g. | 8,769 | \$ | 4,275 | S. | 49.942 | \$ | 12,415 | ||
| Add back: | Ψ | 20,233 | Ψ | 0,703 | Ψ | 4,273 | Ψ | 73,372 | Ψ | 12,415 | ||
| Depreciation and amortization | 10,023 | 12,681 | 1,723 | 32,461 | 7,530 | |||||||
| Selling, general and administrative expense | 1,297 | 1,294 | 1,079 | 4,619 | 3,594 | |||||||
| Acquisition transaction costs | 2,911 | _ | _ | 2,971 | _ | |||||||
| Restructuring charges | 237 | 29 | _ | 266 | _ | |||||||
| Direct margin (Non-GAAP) | \$ | 34,761 | \$ | 22,773 | \$ | 7,077 | \$ | 90,259 | \$ | 23,539 | ||
Direct margin is considered a non-GAAP metric. We define "direct margin" as operating revenues (less reimbursements) less direct operating expenses (less reimbursements). Direct margin is included as a supplemental disclosure because we believe it is useful in assessing and understanding our current operational performance, especially in making comparisons over time. Direct margin is not a substitute for financial measures prepared in accordance with GAAP and should therefore be considered only as supplemental to such GAAP financial measures.

{15}------------------------------------------------
| Interest expense 27,972 29,200 16,124 107,808 29,093 (Gain) loss on investment securities 36,461 337 (13,851) 22,377 (13,953) Foreign currency exchange loss (6,455) 9,216 1,041 9,682 5,550 | Three Months Ended | Year Ended | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (loss) attributable to Helmerich and Payne, Inc. (57,363) (162,758) 75,476 (163,695) 344,165 Add back: Net income attributable to non-controlling interest 1,556 859 — 3,747 — Income tax expense (benefit) (6,265) 28,991 40,878 85,835 136,855 Other (income) expense Interest and dividend income (3,353) (2,856) (11,979) (35,207) (41,168) Interest expense 27,972 29,200 16,124 107,808 29,093 (Gain) loss on investment securities 36,461 337 (13,851) 22,377 (13,953) Foreign currency exchange loss (6,455) 9,216 1,041 9,682 5,550 Other 5,985 (31,258) (102) (27,229) (3,093) Depreciation and amortization 188,857 179,491 100,992 625,085 397,344 Acquisition transaction costs 5,677 8,623 10,452 54,702 14,982 Asset impairment charges 18,928 | Septe | ember 30, | June 30, | Sept | ember 30, | Se | ptember 30, | September 30, | ||||||||||||||||
| Payne, Inc. \$ (57,363) \$ (162,758) \$ 75,476 \$ (163,695) \$ 344,165 Add back: Net income attributable to non-controlling interest 1,556 859 — 3,747 — Income tax expense (benefit) (6,265) 28,991 40,878 85,835 136,855 Other (income) expense — — — — — — 40,878 29,935 — — 136,855 Other (income) expense — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — — </th | (in thousands) | 2025 | 2025 | 2024 | 2025 | 2024 | (in thousands) | 2025 | 2025 | 2024 | 2025 | 2024 | ||||||||||||
| Net income attributable to non-controlling interest 1,556 859 — 3,747 — | \$ | (57,363) | \$ | (162,758) | \$ | 75,476 | \$ | (163,695) | \$ | 344,165 | ||||||||||||||
| interest 1,556 859 — 3,747 — Income tax expense (benefit) (6,265) 28,991 40,878 85,835 136,855 Other (income) expense Interest and dividend income (3,353) (2,856) (11,979) (35,207) (41,168) Interest expense 27,972 29,200 16,124 107,808 29,093 (Gain) loss on investment securities 36,461 337 (13,851) 22,377 (13,953) Foreign currency exchange loss (6,455) 9,216 1,041 9,682 5,550 Other 5,985 (31,258) (102) (27,229) (3,093) Depreciation and amortization 188,857 179,491 100,992 625,085 397,344 Acquisition transaction costs 5,677 8,623 10,452 54,702 14,982 Asset impairment charges 18,928 173,258 — 194,030 — Restructuring charges 7,450 4,681 — 12,131 — Other (gai | Add back: | |||||||||||||||||||||||
| Other (income) expense (3,353) (2,856) (11,979) (35,207) (41,168) Interest and dividend income (3,353) (2,856) (11,979) (35,207) (41,168) Interest expense 27,972 29,200 16,124 107,808 29,093 (Gain) loss on investment securities 36,461 337 (13,851) 22,377 (13,953) Foreign currency exchange loss (6,455) 9,216 1,041 9,682 5,550 Other 5,985 (31,258) (102) (27,229) (3,093) Depreciation and amortization 188,857 179,491 100,992 625,085 397,344 Acquisition transaction costs 5,677 8,623 10,452 54,702 14,982 Asset impairment charges 18,928 173,258 — 194,030 — Restructuring charges 7,450 4,681 — 12,131 — Other (gain) loss on sale of assets (595) 1,347 2,421 1,541 5,139 Excluding Select Items (N | 1,556 | 859 | _ | 3,747 | _ | |||||||||||||||||||
| Interest and dividend income (3,353) (2,856) (11,979) (35,207) (41,168) | Income tax expense (benefit) | (6,265) | 28,991 | 40,878 | 85,835 | 136,855 | ||||||||||||||||||
| Interest expense 27,972 29,200 16,124 107,808 29,093 | Other (income) expense | |||||||||||||||||||||||
| (Gain) loss on investment securities 36,461 337 (13,851) 22,377 (13,953) Foreign currency exchange loss (6,455) 9,216 1,041 9,682 5,550 Other 5,985 (31,258) (102) (27,229) (3,093) Depreciation and amortization 188,857 179,491 100,992 625,085 397,344 Acquisition transaction costs 5,677 8,623 10,452 54,702 14,982 Asset impairment charges 18,928 173,258 — 194,030 — Restructuring charges 7,450 4,681 — 12,131 — Other (gain) loss on sale of assets (595) 1,347 2,421 1,541 5,139 Excluding Select Items (Non-GAAP) Research and development costs associated with an asset acquisition — — — 3,840 Gains related to an insurance claim — — — — 3,840 Credit loss expense associated with long-term note receivable 9,878 — — 9,878 — | Interest and dividend income | (3,353) | (2,856) | (11,979) | (35,207) | (41,168) | ||||||||||||||||||
| Foreign currency exchange loss (6,455) 9,216 1,041 9,682 5,550 | Interest expense | 27,972 | 29,200 | 16,124 | 107,808 | 29,093 | ||||||||||||||||||
| Other 5,985 (31,258) (102) (27,229) (3,093) Depreciation and amortization 188,857 179,491 100,992 625,085 397,344 Acquisition transaction costs 5,677 8,623 10,452 54,702 14,982 Asset impairment charges 18,928 173,258 — 194,030 — Restructuring charges 7,450 4,681 — 12,131 — Other (gain) loss on sale of assets (595) 1,347 2,421 1,541 5,139 Excluding Select Items (Non-GAAP) Research and development costs associated with an asset acquisition — — — 3,840 Gains related to an insurance claim — — — — 3,840 Credit loss expense associated with longterm note receivable 9,878 — — 9,878 — Change in actuarial assumptions on estimated liabilities (3,864) 28,932 — 35,925 — | (Gain) loss on investment securities | 36,461 | 337 | (13,851) | 22,377 | (13,953) | ||||||||||||||||||
| Depreciation and amortization 188,857 179,491 100,992 625,085 397,344 Acquisition transaction costs 5,677 8,623 10,452 54,702 14,982 Asset impairment charges 18,928 173,258 — 194,030 — Restructuring charges 7,450 4,681 — 12,131 — Other (gain) loss on sale of assets (595) 1,347 2,421 1,541 5,139 Excluding Select Items (Non-GAAP) Research and development costs associated with an asset acquisition — — — — — — 3,840 Gains related to an insurance claim — — — — — — — (2,366) — Credit loss expense associated with long-term note receivable 9,878 — — — 9,878 — Change in actuarial assumptions on estimated liabilities (3,864) 28,932 — 35,925 — | Foreign currency exchange loss | (6,455) | 9,216 | 1,041 | 9,682 | 5,550 | ||||||||||||||||||
| Acquisition transaction costs 5,677 8,623 10,452 54,702 14,982 Asset impairment charges 18,928 173,258 — 194,030 — Restructuring charges 7,450 4,681 — 12,131 — Other (gain) loss on sale of assets (595) 1,347 2,421 1,541 5,139 Excluding Select Items (Non-GAAP) Research and development costs associated with an asset acquisition — — — — 3,840 Gains related to an insurance claim — — — — 3,840 Credit loss expense associated with long-term note receivable 9,878 — — 9,878 — Change in actuarial assumptions on estimated liabilities (3,864) 28,932 — 35,925 — | Other | 5,985 | (31,258) | (102) | (27,229) | (3,093) | ||||||||||||||||||
| Asset impairment charges 18,928 173,258 — 194,030 — Restructuring charges 7,450 4,681 — 12,131 — Other (gain) loss on sale of assets (595) 1,347 2,421 1,541 5,139 Excluding Select Items (Non-GAAP) Research and development costs associated with an asset acquisition — — — — — 3,840 Gains related to an insurance claim — — — — 3,840 Credit loss expense associated with long-term note receivable 9,878 — — 9,878 — Change in actuarial assumptions on estimated liabilities (3,864) 28,932 — 35,925 — | Depreciation and amortization | 188,857 | 179,491 | 100,992 | 625,085 | 397,344 | ||||||||||||||||||
| Restructuring charges 7,450 4,681 — 12,131 — | Acquisition transaction costs | 5,677 | 8,623 | 10,452 | 54,702 | 14,982 | ||||||||||||||||||
| Other (gain) loss on sale of assets (595) 1,347 2,421 1,541 5,139 Excluding Select Items (Non-GAAP) Research and development costs associated with an asset acquisition — — — — — — — — — 3,840 Gains related to an insurance claim — — — — — — — — (2,366) — — — — — — — — — — — — — — — — — — | Asset impairment charges | 18,928 | 173,258 | _ | 194,030 | _ | ||||||||||||||||||
| Excluding Select Items (Non-GAAP) Research and development costs associated with an asset acquisition — — — — — — — — 3,840 Gains related to an insurance claim — — — — — — — — — — — — — — — — — — — | Restructuring charges | 7,450 | 4,681 | _ | 12,131 | _ | ||||||||||||||||||
| Research and development costs associated with an asset acquisition — — — — — — 3,840 Gains related to an insurance claim — — — — — — — — — — — — — — — — — — — | Other (gain) loss on sale of assets | (595) | 1,347 | 2,421 | 1,541 | 5,139 | ||||||||||||||||||
| associated with an asset acquisition — — — 3,840 Gains related to an insurance claim — — — (2,366) — Credit loss expense associated with long-term note receivable 9,878 — — 9,878 — Change in actuarial assumptions on estimated liabilities (3,864) 28,932 — 35,925 — | Excluding Select Items (Non-GAAP) | |||||||||||||||||||||||
| Credit loss expense associated with long-term note receivable 9,878 — 9,878 — Change in actuarial assumptions on estimated liabilities (3,864) 28,932 — 35,925 — | _ | _ | _ | _ | 3,840 | |||||||||||||||||||
| term note receivable 9,878 — 9,878 — Change in actuarial assumptions on estimated liabilities (3,864) 28,932 — 35,925 — | Gains related to an insurance claim | _ | _ | _ | (2,366) | _ | ||||||||||||||||||
| estimated liabilities (3,864) 28,932 — 35,925 — | 9,878 | _ | _ | 9,878 | _ | |||||||||||||||||||
| Adjusted EBITDA (Non-GAAP) \$ 224,869 \$ 268,063 \$ 221,452 \$ 934,244 \$ 878,754 | (3,864) | _ | 28,932 | 35,925 | _ | |||||||||||||||||||
| Adjusted EBITDA (Non-GAAP) | \$ | 224,869 | \$ | 268,063 | \$ | 221,452 | \$ | 934,244 | \$ | 878,754 | ||||||||||||||
Adjusted EBITDA and 'Select Items' are considered to be non-GAAP metrics. Adjusted EBITDA is defined as net income(loss) before taxes, depreciation and amortization, gains and losses on asset sales, other income and expense - which includes interest income and interest expense, and excludes the impact of 'select items' which management defines as certain items that do not reflect the ongoing performance of our core business operations. These metrics are included as supplemental disclosures as management uses them to assess and understand current operational performance, especially in analyzing historical trends which are used in forecasting future period results. For this reason, we believe this measure will be useful to information to investors. The presence of non-GAAP metrics is not intended to suggest that such measures should be considered as a substitute for certain GAAP metrics and, given that not all companies define Adjusted EBITDA the same way, this financial measure may not be comparable to similarly titled metrics disclosed by other companies.

{16}------------------------------------------------
| - | Inree Months Ended September 30, 2025 | 5 | ||||||
|---|---|---|---|---|---|---|---|---|
| (in thousands, except per share data) | Pretax | Tax | Net | EPS | ||||
| Net income (GAAP basis) | \$ | (57,363) | \$ | (0.58) | ||||
| (-) Changes in actuarial assumptions on estimated liabilities | \$ | 3\864 | \$ | 877 | \$ | 2,987 | \$ | 0.03 |
| (-) Acquisition transaction costs | \$ | (5,677) | \$ | (680) | \$ | (4,997) | \$ | (0.05) |
| (-) Restructuring charges | \$ | (7,450) | \$ | (595) | \$ | (6,855) | \$ | (0.07) |
| (-) Credit loss expense associated with long-term note receivable | \$ | (9,878) | \$ | (2,242) | \$ | (7,636) | \$ | (80.0) |
| (-) Impairment expense | \$ | (11,450) | \$ | _ | \$ | (11,450) | \$ | (0.12) |
| (-) Loss on investment securities | \$ | (36,461) | \$ | (8,277) | \$ | (28,184) | \$ | (0.28) |
| Adjusted net income | \$ | (1,228) | \$ | (0.01) | ||||
Adjusted EPS and 'Select Items' are considered to be non-GAAP metrics. Adjusted EPS is defined as Earnings Per Share excluding the impact of 'select items'. The Company believes identifying and excluding select items is useful in assessing and understanding current operational performance, especially in making comparisons over time involving previous and subsequent periods and/or forecasting future period results. Select items are excluded as they are deemed to be outside of the Company's core business operations.
| Net capex | Thre e Months Ende d September 30, |
|---|---|
| (in thousands) |
2025 |
| Capital expenditures |
\$64 ,141 |
| from Proceeds asset sales |
\$10 ,853 |
| Net capex |
\$53 ,288 |

{17}------------------------------------------------

For more information, please visit our website at www.hpinc.com
Contact: Kris Nicol Vice President of Investor Relations [email protected]
NYSE: HP
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.